K2M's CASCADIA interbody systems receive FDA clearance: 5 points

Written by Anuja Vaidya | June 01, 2016 | Print  |

K2M received FDA 510(k) clearances to market its CASCADIA Cervical and CASCADIA AN Lordotic Oblique Interbody Systems featuring Lamellar 3D Titanium Technology.

Here are five points:


1. K2M's Lamellar 3D Titanium Technology uses an advanced 3D printing method to create structures that allow for bony integration throughout an implant.


2. The CASCADIA Cervical Interbody System is an intervertebral body fusion device, while the CASCADIA AN Lordotic Oblique Interbody System features a full-range of anatomically designed interbodies for oblique placement through a transforaminal-lumbar approach.


3. All CASCADIA interbody systems are cleared for use with both autologous and allogenic bone graft tissue.


4. The systems are intended for use in treating patients with degenerative disc disease and degenerative scoliosis.


5. Additionally, K2M received FDA clearance to market additional offerings of the two interbody systems.


More articles on devices:
Motus Global develops wearable tech sleeve for pitchers — 5 things to know
NuVasive to attend 2 investor events — 3 quick notes
Medtronic surpasses Zacks' estimates of Q4 earnings, 2016 revenues: 6 points

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months